{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:26:12Z","timestamp":1778685972635,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T00:00:00Z","timestamp":1101945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p><jats:bold>Objective\u2003<\/jats:bold> To compare the efficacy of low dose vaginal misoprostol and dinoprostone vaginal gel for induction of labour at term.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> A single\u2010blind randomised controlled trial.<\/jats:p><jats:p><jats:bold>Setting\u2003<\/jats:bold> Antenatal and labour ward of a UK district general hospital.<\/jats:p><jats:p><jats:bold>Participants\u2003<\/jats:bold> Two hundred and sixty\u2010eight women requiring induction of labour at term (&gt;37 weeks of gestation) with no significant fetal or medical condition, no previous uterine surgery and no contraindication to prostaglandin.<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> Misoprostol 25 \u03bcg (one\u2010quarter of a 100 \u03bcg tablet) was inserted into the posterior vaginal fornix every 4 hours (to a maximum of six doses) or dinoprostone vaginal gel 1\u20132 mg 6 hourly (maximum of 3 mg in 24 hours).<\/jats:p><jats:p><jats:bold>Main outcome measure\u2003<\/jats:bold> Induction\u2010to\u2010vaginal delivery interval.<\/jats:p><jats:p><jats:bold>Secondary outcome measures\u2003<\/jats:bold> Requirements for oxytocin, mode of delivery, number of women delivering &lt;24 hours, incidence of uterine contraction abnormalities, incidence of abnormal cardiotocograph (CTG) recordings, 5\u2010minute Apgar scores, umbilical cord pH recordings, analgesia requirements, admission to NICU and blood loss at delivery.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> There were no significant differences between the two groups in induction\u2010to\u2010vaginal delivery interval, mode of delivery, number of women delivering within 24 hours and neonatal outcomes. The incidence of uterine contraction abnormalities (tachysystole and hyperstimulation) and the incidence of abnormal CTG recordings were also similar for both groups.<\/jats:p><jats:p><jats:bold>Conclusion\u2003<\/jats:bold> Low dose vaginal misoprostol is as effective as dinoprostone gel for inducing labour at term. There would be substantial cost savings, estimated at around \u00a33.9 million per annum, for maternity services if low dose misoprostol became the agent of choice for inducing labour in the UK.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2004.00496.x","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T13:35:06Z","timestamp":1111152906000},"page":"438-444","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["A randomised controlled trial comparing low dose vaginal misoprostol and dinoprostone vaginal gel for inducing labour at term"],"prefix":"10.1111","volume":"112","author":[{"given":"Sarah","family":"Gregson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Waterstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Murrells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,19]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Royal College of Obstetricians and Gynaecologists.Guidelines for best medical practice\/Induction of labour.2001[online]. Available:http:\/\/www.rcog.org.uk\/guidelines\/labour.html. (Accessed 21 January 2004)."},{"key":"e_1_2_6_3_2","unstructured":"British National Formulary 47th edition.British Medical Association and Royal Pharmaceutical Society of Great Britain March2004."},{"key":"e_1_2_6_4_2","first-page":"205","article-title":"Tocographic pattern induced by misoprostol","volume":"106","author":"Neto CM","year":"1988","journal-title":"Rev Paul Med"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-5456(00)00007-3"},{"key":"e_1_2_6_6_2","volume-title":"The Cochrane Library","author":"Alfirevic Z","year":"1999"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-0412.2003.00246.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1999.tb08399.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(96)00374-2"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)91415-3"},{"key":"e_1_2_6_11_2","first-page":"1088","article-title":"Induction of labour with misoprostol in the second and third trimesters of pregnancy","volume":"85","author":"Merrell DA","year":"1995","journal-title":"S Afr Med J"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00553-X"},{"key":"e_1_2_6_13_2","first-page":"96","article-title":"Uterine rupture during preinduction cervical ripening with misoprostol in a patient with a previous caesarian delivery","volume":"38","author":"Scisicone AC","year":"1998","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1999.tb08400.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynaecologists.American College of Obstetricians and Gynaecologists committee opinion. New U.S. Food and Drug Administration labelling on Cytotec (misoprostol) use and pregnancy. Number 283.Int J Gynaecol Obstet2003;82(1):137\u2013138(May).DOI:10.1016\/S0020-7292(03)00248-0","DOI":"10.1016\/S0020-7292(03)00248-0"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)91416-1"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70267-3"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70154-6"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70256-X"},{"key":"e_1_2_6_20_2","first-page":"541","article-title":"Randomised controlled trial of vaginal misoprostol and intracervical prostaglandin E2 gel for induction of labour at term","volume":"86","author":"Varkalis K","year":"1995","journal-title":"Obstet Gynaecol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.00010.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70340-0"},{"key":"e_1_2_6_23_2","first-page":"1159","article-title":"Guidelines for the use of fetal monitoring","volume":"25","author":"International Federation of Gynaecology and Obstetrics (FIGO)","year":"1987","journal-title":"Int J Gynaecol Obstet"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348709022046"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7294.1089"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70199-6"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6661(199905\/06)8:3<114::AID-MFM8>3.3.CO;2-X"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00539-5"},{"key":"e_1_2_6_29_2","unstructured":"National Institute for Clinical Excellence.The use of electronic fetal monitoring.Clinical Guideline C 2001."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440107"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2004.00496.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2004.00496.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T23:24:09Z","timestamp":1695770649000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2004.00496.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,19]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.1471-0528.2004.00496.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2004.00496.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,19]]},"assertion":[{"value":"2005-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}